Provided by Tiger Trade Technology Pte. Ltd.

Global X Genomics & Biotechnology ETF

69.62
+0.84101.22%
Post-market: 69.44-0.1810-0.26%19:49 EDT
Volume:16.76K
Turnover:1.16M
Market Cap:101.97M
PE:- -
High:69.71
Open:69.50
Low:68.72
Close:68.78
52wk High:71.10
52wk Low:40.17
Shares:1.46M
Float Shares:1.46M
Volume Ratio:0.34
T/O Rate:1.14%
Dividend:0.65
Dividend Rate:0.93%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Everpure, Illumina Gain on S&P 500 Inclusion

Reuters
·
Sep 08

Guardant Health initiated with a Buy at Rothschild & Co Redburn

TIPRANKS
·
Sep 08

Natera initiated with a Buy at Rothschild & Co Redburn

TIPRANKS
·
Sep 08

Milton Essex boosts Sanford Biotech capital to drive advanced mastitis cell therapy

TIPRANKS
·
Sep 08

The Second Act of Biotech

TIPRANKS
·
Sep 07

Insiders Shake Up Innovative, Alcoa, Illumina, Southern, Marathon

TIPRANKS
·
Sep 05

S&P 500 Quarterly Shake-Up: AI Demand Propels Bloom Energy Into the Index, Alongside Illumina and Everpure

Stock News
·
Sep 05

Bloom Energy, Illumina, and Everpure Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P Smallcap 600

THOMSON REUTERS
·
Sep 05

Illumina Director Keith Meister Disposes of USD 30.51 Million in Common Shares

Reuters
·
Sep 05

Guardant announces FDA approval of Guardant360 CDx as companion diagnostic

TIPRANKS
·
Sep 05

Guardant Health Announces Landmark FDA Approval of Guardant360® Cdx as Companion Diagnostic for AstraZeneca’s Etcamah™ (Camizestrant) in Advanced Breast Cancer

THOMSON REUTERS
·
Sep 05

S&P Dow Jones Indices: Bloom Energy, Illumina, and Everpure Set to Join S&P 500

THOMSON REUTERS
·
Sep 05

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

Dow Jones
·
Sep 05

Dow Jones Top Company Headlines at 9 am ET: EQT to Buy Insurance Broker McGill in $2 Billion Deal | Tesla-Challenging ...

Dow Jones
·
Sep 04

Natera CEO Steven Leonard Chapman Disposes of 1,698 Common Shares for $545,441.02

Reuters
·
Sep 04

Moderna Chief Legal Officer Shannon Thyme Klinger Disposes of USD 485,271.45 in Common Shares

Reuters
·
Sep 04

Cboe data shows mixed options sentiment in Moderna with shares down 3.87%

TIPRANKS
·
Sep 04

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

Dow Jones
·
Sep 04

Why Moderna Stock's Cancer Vaccine Rally Sparked a Rare Sell Rating

Dow Jones
·
Sep 03

Rothschild & Co Redburn Downgrades Moderna to Sell From Neutral, Adjusts PT to $81 From $40

MT Newswires Live
·
Sep 03